Given C/EBPβ’s role in driving inflammatory responses in neurodegenerative diseases and brain injury by binding to the promoter regions of cytokines and other pro‐inflammatory genes [13], we hypothesized that p21 facilitates an inflammatory phenotype through C/EBPβ‐dependent SASP release. The gene discussed is CEBPB; the disease is neurodegenerative disease.